Evidence map›Paper›PMID 42164397›Full record

ArticleTranslational andrology and urology2026

Development and validation of a discrimination model for benign prostatic hyperplasia: key influencing factors, interaction effects, and the protective role of g-tocopherol.

Jian-Gang Mao

Abstract read
In one paragraph

Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jian-Gang MaoDepartment of Urology, Hangzhou First People's Hospital Tonglu Hospital, Tonglu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Reports on the discrimination of benign prostatic hyperplasia (BPH) are rare. This study investigated the related factors and constructed a model to discriminate the risk of BPH, and also performed an in-depth analysis on key indicators. Methods: The data were collected from the National Health and Nutrition Examination Survey (NHANES) database. The logistic regression analysis was conducted on differential variables between the BPH and non-BPH groups to explore the independent factors of BPH. Then a nomogram discrimination model was constructed and validated, followed by discriminative performance assessment through receiver operating characteristic (ROC) curves, calibration curve, and decision curve analysis (DCA). Further, we deeply analyzed the action mode of core indicators by SHapley Additive exPlanations (SHAP), interaction effect, and subgroup analyses. Results: A total of 4,151 participants were included, with 820 having BPH. The logistic regression results showed that age, race, smoking, alcoholic drinks, waist circumference (WC), g-tocopherol, and free prostate-specific antigen (PSA) were independently related to BPH. A nomogram constructed by the seven factors had a great discriminative performance on BPH both in training sets and validation sets, and can obtain a favorable clinical net benefit. Within the discrimination model, age, PSA, and WC were the more core influencing factors, and they can jointly amplify the risk of BPH. The effect of g-tocopherol was regulated by these background factors. Conclusions: This study identified key factors and constructed a useful tool for discriminating BPH, and also revealed the action mode of core factors. It provides a scientific basis for risk discrimination and key mechanism analysis of BPH.

Indexed as

Benign prostatic hyperplasia (BPH)g-tocopherolprostate-specific antigen (PSA)risk factors

Identifiers

PMID42164397
PMCPMC13184240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.